RightFit
RecruitingNot applicable

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

Young Adults and Violent Behavior During Early Psychosis (Aim 3)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
16 Years to 30 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether BRAVE is practical to use and accepted by young people ages 16–30 with early psychosis, a condition that can make it hard to tell what is real. BRAVE uses talk therapy to address factors linked to violence risk. Everyone will get their usual care first, then BRAVE, while researchers track violence-related behavior and involvement in treatment.

This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Are 16–30 years old.
  • Have been diagnosed with early psychosis.
  • Get care at an early psychosis clinic without staying overnight.
  • Have stable mental health symptoms, and your treating clinician says you can take part.
  • Can and want to give informed consent, meaning you understand the study and agree to join.

Who can't join

  • Cannot give informed consent.
  • Are not fluent in English.
  • Have a history of antisocial behavior, such as behavior that harms others or violates their rights, as checked at the start of the study.
  • Have an immediate safety risk that requires more intensive care.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Young adults aged 16-30 years * Diagnosis of early psychosis * Currently receiving outpatient care through an early psychosis clinic * Psychiatrically stable and deemed appropriate for participation by a treating clinician * Able and willing to provide informed consent Exclusion Criteria: * Unable to provide informed consent * Not fluent in English * History of antisocial behavior, as assessed at baseline * Immediate risk requiring a higher level of care

Study sites (2)

DC